Fulcrum Therapeutics Inc (FULC)
$4.03 -$0.24 (-5.62%) 10:07 AM 12/12/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$215.22M -
Day's Range
$3.99 - $4.28 -
Volume
806,218 -
52 Week Low / High
$2.86 - $13.70 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
FULC's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 1
- Strong Buy
- 1
- Buy
- 5
- Hold
- 1
- Sell
- 0
- Strong Sell
- $10.21
- Target Price
Company News
-
RA Capital Management's Strategic Acquisition of Fulcrum Therapeutics Shares — Sep 17th, 2024
Overview of Recent Transaction On September 12, 2024, RA Capital Management, L.P., a prominent investment firm, significantly increased its stake in Fulcrum Therapeutics Inc (NASDAQ:FULC) by acquiring an additional 4,684,883 shares. This transaction was executed at a price of $3.44 per sh...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$